FDA Inspection
Lovelace Biomedical Research InstituteLovelace Biomedical Research Institute – FDA Inspection, Nov 11, 2016
Record Details
This FDA Inspection record concerns Lovelace Biomedical Research Institute, with an inspection on November 11, 2016, issued by the Denver District Office, covering human drugs.
- Inspection Date
- November 11, 2016
- Product Type
- Human Drugs
View Company Profile
ID · f6e21a15-ef32-47e1-b2ee-a293b86c8be1
Inspection Facts
- Inspection number
- 998362
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lovelace Biomedical Research Institute
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2025 | Not classified | Denver District Office | Bioresearch Monitoring: Human Drugs |
| September 14, 2023 | Not classified | Denver District Office | |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 13, 2019 | VAI | Denver District Office | Bioresearch Monitoring |
Other documents for Lovelace Biomedical Research Institute
- FDA Inspection 1267403 - 2025-04-18
- FDA Inspection 1220523 - 2023-09-14
- FDA Inspection 1118971 - 2020-01-31
- FDA Inspection 1101842 - 2019-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.